Pfizer estimates $15 bn in 2021 sales for COVID-19 vaccine
AFP
1612268299000
Sales of the COVID-19 vaccine developed by Pfizer and BioNTech could reach up to $15 billion in 2021 and go higher if Pfizer signs additional supply contracts, Pfizer said Tuesday.
The projections came as Pfizer reported fourth-quarter and full-year profits and released forecasts for 2021. Pfizer projected full-year 2021 sales of between $44.4 to $46.4 billion, excluding sales for the COVID-19 vaccine.